Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hedaquinium SCHEMBL29385501 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL14951081 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3609804 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3599717 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3594886 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL3605119 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Hedaquinium SCHEMBL14637924 | 1.00 | BCHE (1.00) | BCHEACHE | |
| SCHEMBL4890048 | 1.00 | BCHE (1.00) | BCHEACHE | |
| Bromide SCHEMBL4890409 | 0.98 | BCHE (1.00) | BCHEACHE | |
| Iodide SCHEMBL2333225 | 0.98 | BCHE (0.96) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152237-A1 | BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-06-17 | — | — | US | claimed |
| US-20080287490-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2008-11-20 | — | — | US | claimed |
| US-20050261334-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2005-11-24 | — | — | US | claimed |
| US-20180135187-A1 | Corrosion Inhibition | SCHLUMBERGER TECHNOLOGY CORPORATION | 2018-05-17 | — | — | US | disclosed |
| US-9839591-B2 | Anionic dye or brightener bearing an ammonium or phosphonium counterion, dye composition comprising them and process for dyeing keratin fibres using these dyes | L'OREAL (FR) | 2017-12-12 | — | — | US | disclosed |
| WO-2016167837-A1 | CORROSION INHIBITION | SCHLUMBERGER CANADA LIMITED (CA) | 2016-10-20 | — | — | WO | disclosed |
| US-20150113742-A1 | ANIONIC DYE OR BRIGHTENER BEARING AN AMMONIUM OR PHOSPHONIUM COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN FIBRES USING THESE DYES | L'OREAL (FR) | 2015-04-30 | — | — | US | disclosed |
| US-8546415-B2 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | KH NEOCHEM CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
| WO-2012008468-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | 協和発酵ケミカル株式会社 (JP) | 2012-01-19 | — | — | WO | disclosed |
| US-20100152237-A1 | BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-06-17 | — | — | US | disclosed |
| US-20080287490-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2008-11-20 | — | — | US | disclosed |
| US-20050261334-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150113742-A1 | ANIONIC DYE OR BRIGHTENER BEARING AN AMMONIUM OR PHOSPHONIUM COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN FIBRES USING THESE DYES | KRT18, IK, COL14A1 | BCHE 2753/4885ACHE 2056/4885 |
| US-20100152237-A1 | BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES | SLC18A3, CHRNB2, CHRNB3 | BCHE 66/4885ACHE 42/4885 |
| US-20050261334-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | SLC18A3, SLC18A2, CHRNB2 | BCHE 58/4885ACHE 43/4885 |
| US-20080287490-A1 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | SLC18A3, SLC18A2, CHRNB2 | BCHE 58/4885ACHE 43/4885 |
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | TRPA1, KCNH3, HCN3 | BCHE 1940/4885ACHE 518/4885 |
| US-20180135187-A1 | Corrosion Inhibition | SOD1, AOC1, NOX1 | BCHE 3671/4885ACHE 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.